When was HEPTA Medical founded?

HEPTA Medical was founded in 2018 and raised its 1st funding round 6 years after it was founded.

Where is HEPTA Medical located?

HEPTA Medical is headquartered in Paris, France.

Who is the current CEO of HEPTA Medical?

Thomas Bancel of HEPTA Medical.

How many employees does HEPTA Medical have?

As of Sep 30, 2026, the latest employee count at HEPTA Medical is 16.

Is HEPTA Medical a funded company?

HEPTA Medical is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Sep 04, 2024.

When was the latest funding round of HEPTA Medical?

HEPTA Medical's latest funding was a $***** Series A round on Sep 04, 2024, with participation from 3 investors.

Where does HEPTA Medical rank among its competitors?

HEPTA Medical ranks 4th amongst 15 active competitors, of which 7 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Combat Medical, which secured $3.49M in Aug, 2025.

Who are the top competitors of HEPTA Medical?

HEPTA Medical's top competitors include Francis Medical, NxThera and Combat Medical. Among them, Combat Medical secured the most recent funding round in August, 2025.

HEPTA Medical - 2026 Company Profile, Team, Funding & Competitors

HEPTA Medical is a series A company based in Paris (France), founded in 2018. It operates as a Developer of minimally invasive non-surgical treatment for cancer. HEPTA Medical has raised $6.3M in funding from Bpifrance. The company has 15 active competitors, including 7 funded and 1 that has exited. Its top competitors include companies like Francis Medical, NxThera and Combat Medical.

Company Details

Developer of minimally invasive non-surgical treatment for cancer. The company is developing an endoscopically delivered ablation catheter that uses temperature-based feedback and real-time dosing to precisely target and ablates pulmonary nodules, the precursor of lung cancer.

Website: www.heptamed.com/
Email ID: *****@heptamed.com

Key Metrics

Founded Year

2018

Location

Paris, France

Stage

Series A

Total Funding

$6.3M in 1 round

Latest Funding Round

Series A, Sep 04, 2024, $*****

Investors

Bpifrance & 3 more

Ranked

4^th among 15 active competitors

Employee Count

16 as on Sep 30, 2026

Similar Companies

Vivos & 2 more

View HEPTA Medical's full profile

HEPTA Medical has raised a total funding of $6.3M over 1 round. Its latest funding round was a Series A round on Sep 04, 2024 for $*****. 3 investors participated in its latest round. HEPTA Medical has 4 institutional investors.

Here is the list of recent funding rounds of HEPTA Medical:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 04, 2024	9167875	Series A	8110507	6419215	8439123	6151603

Access funding benchmarks and valuations. Sign up today!

View details of HEPTA Medical's funding rounds and investors

HEPTA Medical's employee count trend

HEPTA Medical has 16 employees as of Sep 26. Here is HEPTA Medical's employee count trend over the years:

Uncover HEPTA Medical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of HEPTA Medical include Francis Medical, NxThera and Combat Medical. Here is the list of Top 10 competitors of HEPTA Medical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Francis Medical 2018, Maple Grove (United States), Series C	Developer of a therapeutic solution to treat prostate, kidney, and bladder cancer	$157M	Arboretum Ventures, Solas BioVentures & 5 others	59/100
2nd	NxThera 2008, Maple Grove (United States), Acquired	Developer of thermal therapy for Benign Prostatic Hyperplasia(BPH)	$148M	Arboretum Ventures, Aberdare Ventures & 8 others	45/100
3rd	Combat Medical 2008, Wheathampstead (United Kingdom), Series A	Manufacturer of medical device for curing bladder cancer	$4.17M	T and J Meyer Family Foundation, W Angel Fund ... & 25 others	45/100
4th	HEPTA Medical 2018, Paris (France), Series A	Developer of minimally invasive non-surgical treatment for cancer	$6.3M	Bpifrance, Supernova Invest & 2 others	37/100
5th	Hygea Medical Technology 2013, Series D	Manufacturer of tumor minimally invasive interventional therapy and ablation systems	$120M	China Growth Capital, Yueyin Medical Fund ... & 10 others	34/100
6th	MedWaves 1998, San Diego (United States), Series A	Innovative medical technology company specializing in minimally invasive therapeutic systems	$3M	Amkey Ventures	30/100
7th	Kaio Therapy 2012, Raleigh (United States), Seed	Developer of hyperthermia-based cancer therapeutic platform	$3.91M	-	27/100
8th	PhotoQ3 2019, Chiyoda City (Japan), Seed	Developer of therapeutic technology for cancer treatment	$1.75M	DEFTA Partners	27/100
9th	Meijie Medical 2016, Xuhui (China), Unfunded	Developer of multimodal thermal physical ablation immunotherapy for tumors	-	-	24/100
10th	Triton BioSystems 2019, Chelmsford (United States), Funding Raised	Developing non-invasive targeted therapy for cancer patients	-	Millennium Materials Technologies Fund	22/100